IP Library Patent Application 14089091
Patent Application
App. No. 14/089,091

ANTIMICROBIAL COMPOSITION EXHIBITING INCREASED EFFICACY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/089,091
Abstract

Materials and apparatus are provided that exhibit increased efficacy. An antimicrobial composition includes a cationic active ingredient disposed within the antimicrobial composition. Further, the antimicrobial composition includes a lauramine oxide surfactant, the lauramine oxide surfactant comprising 0.9 to 1.9 weight percent of the antimicrobial composition. Further, the antimicrobial composition includes a number of co-surfactants, the co-surfactant comprising cocamidopropyl betaine, sunfloweramidopropyl ethonium sulfate, PEG-120 methyl glucose dioleate, lauryl/myristyl amidopropyl amine oxide, lauramidopropylamine oxide, or combinations thereof. Still further, the antimicrobial composition includes a thickener, the thickener comprising hydromethylcellulose, PEG-120 methyl glucose, cocamide MEA, hydroxypropyl methylcellulose or combinations thereof.

Claims (35)

1 . An antimicrobial composition exhibiting increased efficacy, comprising:

a cationic active ingredient comprising benzethonium chloride at a concentration of 0.1 to 0.2 weight percent of the antimicrobial composition;

a lauramine oxide surfactant, at a concentration of 0.9 to 1.9 weight percent of the antimicrobial composition;

one or more co-surfactants selected from the group consisting of cocamidopropyl betaine, sunfloweramidopropyl ethonium sulfate, PEG-120 methyl glucose dioleate, lauryl/myristyl amidopropyl amine oxide, and lauramidopropylamine oxide; and

one or more thickeners selected from the group consisting of hydromethylcellulose, PEG-120 methyl glucose, cocamide MEA, and hydroxypropyl methylcellulose,

wherein the antimicrobial composition causes at least a log 2 reduction in a bacterial population on a skin surface.

2 - 3 . (canceled)

4 . The antimicrobial composition of claim 1 , in which the antimicrobial composition exhibits an accumulation effect after multiple uses.

5 . The antimicrobial composition of claim 1 , further comprising a dye, a fragrance, a preservative, a PH adjuster, an antiseptic, a humectant, or combinations thereof.

6 . The antimicrobial composition of claim 1 , in which the lauramine oxide comprises 1.50 percent weight of the antimicrobial composition.

7 . The antimicrobial composition of claim 1 , in which the antimicrobial composition is configured to be applied on skin.

8 . The antimicrobial composition of claim 1 , further comprising a zinc salt.

9 . The antimicrobial composition of claim 8 , in which the zinc salt is zinc sulfate, zinc gluconate, or combinations thereof.

10 . An antimicrobial cleansing product exhibiting increased efficacy, comprising:

a container;

an antimicrobial composition housed within the container, wherein the antimicrobial composition comprises:

a cationic active ingredient comprising benzethonium chloride at a concentration of 0.1 to 0.2 weight percent of the antimicrobial composition;

a lauramine oxide surfactant at a concentration of 0.9 to 1.9 weight percent of the antimicrobial composition;

one or more co-surfactants selected from the group consisting of cocamidopropyl betaine, sunfloweramidopropyl ethonium sulfate, PEG-120 methyl glucose dioleate, lauryl/myristyl amidopropyl amine oxide, and lauramidopropylamine oxide;

one or more thickeners selected from the group consisting of hydromethylcellulose, PEG-120 methyl glucose, cocamide MEA, and hydroxypropyl methylcellulose; and

an aqueous carrier to contain the antimicrobial cleaning product.

11 . The product of claim 10 , in which the antimicrobial composition is a gel.

12 . The product of claim 10 , in which the antimicrobial composition is a foam.

13 . The product of claim 10 , in which the container comprises an opening that allows the antimicrobial composition to flow out of the container.

14 . The product of claim 10 , in which the antimicrobial composition is configured to be applied on skin.

15 . The product of claim 10 , in which the antimicrobial composition facilitates at least a log 2 reduction in a bacterial population.

16 . The product of claim 10 , in which the antimicrobial composition further comprises a zinc salt.

17 . (canceled)

18 . An antimicrobial composition exhibiting increased efficacy, comprising:

0.10% to 0.20% by weight of benzethonium chloride disposed within the antimicrobial composition;

0.9% to 1.9% by weight of a lauramine oxide surfactant disposed within the antimicrobial composition;

one or more co-surfactants disposed within the antimicrobial composition; and

a thickener disposed within the antimicrobial composition.

19 . The antimicrobial composition of claim 18 in which the number of co-surfactants comprise cocamidopropyl betaine, sunfloweramidopropyl ethonium sulfate, PEG-120 methyl glucose dioleate, lauryl/myristyl amidopropyl amine oxide, lauramidopropylamine oxide, or combinations thereof.

20 . The antimicrobial composition of claim 18 in which the thickener comprises hydromethylcellulose, PEG-120 methyl glucose, cocamide MEA, hydroxypropyl methylcellulose, or combinations thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2017
From: HENKEL US IV CORPORATION
To: HENKEL IP & HOLDING GMBH
Reel/Frame 042108/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2017
From: THE DIAL CORPORATION
To: HENKEL US IV CORPORATION
Reel/Frame 041671/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2013
From: FULS, JANICE L.; RODGERS, NANCY D.
To: THE DIAL CORPORATION
Reel/Frame 031670/0782 →